USA Rare Earth (NASDAQ: USAR) closed Friday at $19.26, up 12.57% on heavy volume of approximately 21.2 million shares. Despite the sharp daily gain, the stock remains below its $20.00 close from a week earlier, reflecting a 3.7% weekly decline. The late-week rebound has restored some momentum, but the real test comes on August 28 when shareholders vote on the proposed acquisition of Serra Verde.
The vote is the final stated condition for closing the deal, according to management. Completion is expected shortly after the vote passes. The acquisition is central to USA Rare Earth's strategy of becoming a major non-Asian producer of magnetic rare earths.
Friday's rally was part of a broader surge in Western critical-minerals stocks. New Chinese trade data highlighted the strategic importance of the sector. According to Reuters, U.S. imports of yttrium oxide reached 29 metric tons in July, the second-highest monthly level since April 2025 export controls were introduced. While supply has improved, geopolitical leverage remains a key concern.
Among peers, Critical Metals Corp. (NASDAQ: CRML) jumped 22.59% to $7.11, while MP Materials Corp. (NYSE: MP) gained 9.10% to $60.05. The sector's performance underscores the market's growing focus on rare earth supply chain security.
The Serra Verde Deal: High Reward, High Dilution
The proposed transaction involves USA Rare Earth paying $300 million in cash and issuing 126.849 million shares. These new shares represent approximately 52% of the company's current 244.7 million share count and would account for roughly 34% of the combined basic share count. The dilution is significant, but the strategic value of Serra Verde's Pela Ema operation in Brazil is substantial—it is the only scaled non-Asian producer of all four magnetic rare earths.
Analysts are optimistic about the deal's upside. Benchmark's Subash Chandra reiterated a Buy rating with a $45 price target on August 12. Northland Securities' Jeff Grampp also maintained a Buy with a $45 target on August 11. Cantor Fitzgerald's Derek Soderberg reiterated Overweight with a $40 target the same day. The average analyst target stands at $37.38, implying roughly 94% upside from Friday's close.
Financial Reality: Losses and Liquidity
Despite the strategic appeal, USA Rare Earth's financials show early-stage challenges. Q2 revenue was $5.82 million, with a gross loss of $1.58 million. The adjusted net loss widened to $33.48 million, and H1 operating cash use plus capital expenditures and deposits totaled about $183.7 million, roughly 12% of the $1.53 billion cash on hand as of June 30. The company has a large funded runway, but scaling operations continues to consume liquidity.
The Department of Commerce package, which includes up to $277 million in grants and $1.3 billion in senior loans, is milestone-based. Disbursements depend on project achievements, so investors must distinguish between announced capacity and funded, operating capacity.
Production Targets and Market Valuation
Management targets 600 metric tons of annualized magnet capacity at Stillwater by Q4 and expects Serra Verde to reach 6,400 metric tons of rare-earth oxide capacity by the end of 2027. The latter target carries a preliminary annualized EBITDA estimate of $550 million to $650 million—a company projection that remains unverified.
At Friday's price, USA Rare Earth's equity value was about $4.7 billion, more than 200 times annualized Q2 revenue. This multiple is crude because Serra Verde has not yet closed, but it illustrates how much future output is already priced in.
Execution and Risks
Barbara Humpton emphasized the company's transition from assembling operations to delivering for customers. Q2 revenue came from Less Common Metals, with initial magnet sales expected by year-end. However, risks remain: the Serra Verde vote or closing could slip, ramp-up costs may exceed forecasts, new shares dilute current holders, and customer qualification, commodity prices, Brazil exposure, and milestone-linked federal funding add uncertainty.
Next week's shareholder vote will be a critical test. Investors will also watch for closing terms and any updated production timetable. Until then, USAR remains a funded execution story with unusually high sensitivity to each operating milestone.
